Loading...
XJPX
6856
Market cap3.14bUSD
Jun 06, Last price  
10,840.00JPY
1D
0.00%
1Q
10.06%
Jan 2017
100.37%
Name

Horiba Ltd

Chart & Performance

D1W1MN
P/E
13.54
P/S
1.43
EPS
800.69
Div Yield, %
2.44%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
9.65%
Revenues
317.37b
+9.23%
105,664,560,000116,099,308,000144,283,000,000134,247,000,000104,538,000,000118,556,000,000123,456,000,000117,609,000,000138,136,000,000153,065,000,000170,898,000,000170,093,000,000195,399,000,000210,570,000,000200,241,000,000187,080,000,000224,314,000,000270,133,000,000290,558,000,000317,369,000,000
Net income
33.59b
-16.65%
6,473,422,0006,510,280,0008,690,000,0006,039,000,0003,161,000,0007,927,000,0008,664,000,0007,396,000,0008,999,000,00010,589,000,00012,882,000,00012,962,000,00016,281,000,00022,313,000,00015,481,000,00013,188,000,00021,311,000,00034,072,000,00040,302,000,00033,591,000,000
CFO
40.34b
+142.22%
8,672,639,0003,769,542,00013,581,000,0007,521,000,00013,711,000,00011,964,000,0006,954,000,00013,395,000,00015,076,000,00011,455,000,00014,770,000,00015,871,000,00028,287,000,00019,536,000,00026,638,000,00032,253,000,00035,268,000,00033,966,000,00016,652,000,00040,335,000,000
Dividend
Jun 27, 20250 JPY/sh
Earnings
Aug 06, 2025

Profile

HORIBA, Ltd. manufactures and sells instruments and systems for various applications. It operates in five segments: Automotive, Process & Environmental, Medical-Diagnostic, Semiconductor, and Scientific. The Automotive segment offers automotive emission analyzers, emission measurement systems, drive line test systems, engine test and fuel cell test systems, and battery test systems; test systems for engines, chassis, powertrains, brakes, and catalysts; and vehicle development engineering and testing engineering services, as well as leases and manages R&D facilities. The Process & Environmental segment provides stack gas analyzers, industrial water quality analyzers, water quality analysis and examination systems, air pollution analyzers, environmental radiation meters, and process measurement equipment. The Medical-Diagnostic segment offers hematology and CRP, immunology, clinical chemistry, and blood glucose analyzers. The Semiconductor Instruments & Systems segment provides mass flow controllers, chemical concentration monitors, reticle/mask particle detection systems, residual gas analyzers, and vaporizers. The Scientific segment offers Raman spectrometers, pH meters, particle-size distribution analyzers, X-Ray fluorescence analyzers, elemental analyzers, fluorescence spectroscopy/fluorescence lifetime spectroscopy, optical components, spectrometers and detectors, and gratings. The company was founded in 1945 and is headquartered in Kyoto, Japan.
URL
https://www.horiba.com/int/
IPO date
Mar 22, 1971
Employees
8,432
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
317,369,000
9.23%
290,558,000
7.56%
270,133,000
20.43%
Cost of revenue
180,514,000
183,610,000
172,044,000
Unusual Expense (Income)
NOPBT
136,855,000
106,948,000
98,089,000
NOPBT Margin
43.12%
36.81%
36.31%
Operating Taxes
15,233,000
13,400,000
13,199,000
Tax Rate
11.13%
12.53%
13.46%
NOPAT
121,622,000
93,548,000
84,890,000
Net income
33,591,000
-16.65%
40,302,000
18.28%
34,072,000
59.88%
Dividends
(12,228,000)
(10,973,000)
(6,959,000)
Dividend yield
3.16%
2.34%
2.86%
Proceeds from repurchase of equity
(5,017,000)
BB yield
1.30%
Debt
Debt current
9,013,000
5,695,000
12,351,000
Long-term debt
55,391,000
57,429,000
57,573,000
Deferred revenue
Other long-term liabilities
11,239,000
8,905,000
7,541,000
Net debt
(101,188,000)
(87,317,000)
(80,406,000)
Cash flow
Cash from operating activities
40,335,000
16,652,000
33,966,000
CAPEX
(18,152,000)
(8,849,000)
(12,083,000)
Cash from investing activities
(17,562,000)
(7,315,000)
(10,745,000)
Cash from financing activities
(15,933,000)
(20,963,000)
(22,447,000)
FCF
96,486,000
49,535,000
66,152,000
Balance
Cash
146,334,000
134,775,000
141,354,000
Long term investments
19,258,000
15,666,000
8,976,000
Excess cash
149,723,550
135,913,100
136,823,350
Stockholders' equity
253,851,000
266,001,000
223,356,000
Invested Capital
240,622,450
217,115,900
169,637,650
ROIC
53.14%
48.38%
53.30%
ROCE
35.06%
30.24%
31.87%
EV
Common stock shares outstanding
42,235
42,475
42,437
Price
9,152.00
-17.03%
11,030.00
92.50%
5,730.00
-15.24%
Market cap
386,532,597
-17.50%
468,499,250
92.67%
243,164,010
-15.19%
EV
285,358,597
381,199,250
162,773,010
EBITDA
149,914,000
119,550,000
109,437,000
EV/EBITDA
1.90
3.19
1.49
Interest
924,000
722,000
657,000
Interest/NOPBT
0.68%
0.68%
0.67%